Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' (Deficit) Equity

v3.19.1
Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2016 155,762,729          
Balance at Dec. 31, 2016 $ 155,763 $ 326,564,148 $ (394,855,034) $ 468,910 $ (67,666,213)
Issued stock in payment of Board retainers (in shares) 16,406          
Stock Issued During Period, Value, Issued for Services $ 17 10,483 10,500
Issued stock in payment of employee bonuses (in shares) 710,353          
Issued stock in payment of employee bonuses $ 710 368,632 369,342
Issued stock upon exercise of warrants (in shares) 5,411,850          
Issued stock upon exercise of warrants $ 5,412 48,707 54,119
Issued warrants in connection with Asset Sale 3,337,187 3,337,187
Issued warrants for extension of license agreement 333,719 $ 333,719
Issued stock to 401(k) plan (in shares) 105,308         105,308
Issued stock to 401(k) plan $ 105 53,602 $ 53,707
Issued restricted stock (in shares) 200,000          
Issued restricted stock $ 200 200
Canceled forfeited restricted stock (in shares) (50,000)          
Canceled forfeited restricted stock $ (50) 50
Issued stock upon exercise of stock options (in shares) 50,000         50,000
Issued stock upon exercise of stock options $ 50 18,050 $ 18,100
Stock compensation expense 394,209 394,209
Net income (loss) 74,946,066 (210) 74,945,856
Unrealized gain (loss) on available-for-sale securities (2,396) (2,396)
Total comprehensive income (loss) 74,943,460
Reclassification of funds invested (Note 10) 200,000 200,000
Balance (in shares) at Dec. 31, 2017 162,206,646          
Balance at Dec. 31, 2017 $ 162,207 331,128,787 (319,908,968) (2,396) 668,700 12,048,330
Issued stock in payment of employee bonuses (in shares) 1,118,760          
Issued stock in payment of employee bonuses $ 1,118 315,784 $ 316,902
Issued stock to 401(k) plan (in shares) 94,684         94,684
Issued stock to 401(k) plan $ 95 35,885 $ 35,980
Issued restricted stock (in shares) 200,000          
Issued restricted stock $ 200 200
Canceled forfeited restricted stock (in shares) (50,000)          
Canceled forfeited restricted stock $ (50) 50
Issued stock upon exercise of stock options (in shares)          
Stock compensation expense 306,698 $ 306,698
Net income (loss) (16,113,937) (379) (16,114,316)
Unrealized gain (loss) on available-for-sale securities 1,666 1,666
Total comprehensive income (loss) (16,112,650)
Impact of adoption of ASC Topic 606 at Dec. 31, 2017 (700,000) (700,000)
Issued stock pursuant to private placement (in shares) 18,320,610          
Issued stock pursuant to private placement $ 18,321 2,981,679 3,000,000
Issued stock pursuant to termination agreement (in shares) 18,500,000          
Issued stock pursuant to termination agreement $ 18,500 3,496,500 3,515,000
Balance (in shares) at Dec. 31, 2018 200,390,700          
Balance at Dec. 31, 2018 $ 200,391 $ 338,265,383 $ (336,722,905) $ (730) $ 668,321 $ 2,410,460